Global Health Ltd.
NSE: MEDANTA · Hospital
Snapshot
Unlock Global Health Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Global Health Limited is a multi-specialty tertiary care provider operating under the Medanta brand. The company delivers advanced medical treatments across various disciplines including cardiology, neurosciences, oncology, and organ transplantation through its network of hospitals in India.
Business Model
The company generates revenue by providing comprehensive healthcare services, including inpatient and outpatient care, diagnostic services, and complex surgical procedures. It operates a hub-and-spoke model with large-scale hospitals located in key Indian cities.
Growth Outlook
Growth is driven by the expansion of bed capacity across its existing hospital network and the increasing demand for high-end tertiary and quaternary care services in India. The company continues to focus on clinical excellence and the integration of advanced medical technologies.
Key Risks
- Regulatory Risk. Changes in government healthcare policies or price caps on medical procedures and drugs could adversely impact profit margins.
- Talent Retention. The hospital sector faces intense competition for skilled medical professionals, including doctors and nursing staff, which may affect service quality and operational costs.
- Operational Concentration. The company's performance is heavily dependent on the operational success of its specific hospital locations in Gurugram, Indore, Ranchi, and Lucknow.
- Medical Liability. Healthcare providers are subject to inherent risks of medical malpractice claims and litigation, which can result in significant financial and reputational damage.
Price
Start your research today
Unlock AI insights, financials, peers and live data on Global Health Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹4,410 Cr
TTM · consolidated
NET PROFIT
₹554 Cr
TTM · consolidated
EPS
₹20.71
TTM · consolidated
RETURN ON EQUITY
15.7%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
17.9%
TTM · consolidated
P/E
64.3x
Q4 FY26 · consolidated
EV/EBITDA
36.2x
Q4 FY26 · consolidated
EBITDA MARGIN
23.1%
TTM · consolidated
NET PROFIT MARGIN
12.2%
Q4 FY26 · consolidated
DEBT TO EQUITY
0.3x
Q4 FY26 · consolidated
Peers · Hospital
| Company | Mkt Cap (Cr) | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Global Health Ltd.MEDANTA | 26,256 | 64.33 | 36.24 | 19.4% | 23.1% | 15.7% | 17.9% | -0.5% |
Narayana Hrudayalaya Ltd.NH | 33,944 | 51.02 | 26.46 | 41.4% | 21.7% | 20.9% | 16.8% | +4.3% |
Aster Dm Healthcare Ltd.ASTERDM | 33,082 | 107.71 | 41.45 | -45.3% | 45.4% | 16.6% | 18.0% | +35.4% |
Krishna Institute Of Medical Sciences LtdKIMS | 25,254 | 133.38 | 42.64 | 28.7% | 21.2% | 11.2% | 10.1% | +8.1% |
Dr Agarwals Eye Hospital Ltd.AGARWALEYE | 13,353 | 116.90 | 25.52 | — | 29.5% | 8.8% | 10.4% | +13.9% |
Rainbow Childrens Medicare LtdRAINBOW | 11,636 | 54.39 | 25.70 | 12.4% | 34.5% | 18.6% | 18.8% | -3.4% |
As of Q4 FY26
Financials
Global Health Ltd.
NSE: MEDANTA · Hospital
Snapshot
Unlock Global Health Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Global Health Limited is a multi-specialty tertiary care provider operating under the Medanta brand. The company delivers advanced medical treatments across various disciplines including cardiology, neurosciences, oncology, and organ transplantation through its network of hospitals in India.
Business Model
The company generates revenue by providing comprehensive healthcare services, including inpatient and outpatient care, diagnostic services, and complex surgical procedures. It operates a hub-and-spoke model with large-scale hospitals located in key Indian cities.
Growth Outlook
Growth is driven by the expansion of bed capacity across its existing hospital network and the increasing demand for high-end tertiary and quaternary care services in India. The company continues to focus on clinical excellence and the integration of advanced medical technologies.
Key Risks
- Regulatory Risk. Changes in government healthcare policies or price caps on medical procedures and drugs could adversely impact profit margins.
- Talent Retention. The hospital sector faces intense competition for skilled medical professionals, including doctors and nursing staff, which may affect service quality and operational costs.
- Operational Concentration. The company's performance is heavily dependent on the operational success of its specific hospital locations in Gurugram, Indore, Ranchi, and Lucknow.
- Medical Liability. Healthcare providers are subject to inherent risks of medical malpractice claims and litigation, which can result in significant financial and reputational damage.
Price
Loading…
Start your research today
Unlock AI insights, financials, peers and live data on Global Health Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹4,410 Cr
TTM · consolidated
NET PROFIT
₹554 Cr
TTM · consolidated
EPS
₹20.71
TTM · consolidated
RETURN ON EQUITY
15.7%
TTM · consolidated
RETURN ON CAPITAL EMPLOYED
17.9%
TTM · consolidated
P/E
64.3x
Q4 FY26 · consolidated
EV/EBITDA
36.2x
Q4 FY26 · consolidated
EBITDA MARGIN
23.1%
TTM · consolidated
NET PROFIT MARGIN
12.2%
Q4 FY26 · consolidated
DEBT TO EQUITY
0.3x
Q4 FY26 · consolidated
Peers · Hospital
As of Q4 FY26